Jie Shi

864 citations
48 papers · 644 indexed · h-index 13
Topics
Acute Myeloid Leukemia Research (6 papers)Multiple Myeloma Research and Treatments (5 papers)Cancer-related molecular mechanisms research (5 papers)
Journals
SHILAP Revista de lepidopterologíaBloodPLoS ONE

In The Last Decade

Jie Shi

42 papers receiving 635 citations

Peers

Jie Shi
Comparison fields: 5 of 87
  • Molecular Biology 366
  • Cancer Research 300
  • Oncology 127
  • Immunology 107
  • Hematology 73
Replace Lan Dai with:
Lan Dai China
Anjian Xu China
Jinchul Kim South Korea
Noriko Tanaka Japan
Yuting Yi China
Durga Attili United States
Weilong Zhang China
Malcolm Mason United Kingdom
Jie Shi relative to Lan Dai China Lan Dai's profile →
Citations per field
00.5×1.5×
Lan Dai · 1×
Citations per year

Countries citing papers authored by Jie Shi

Since Specialization
Citations

This map shows the geographic impact of Jie Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jie Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jie Shi more than expected).

Fields of papers citing papers by Jie Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jie Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jie Shi. The network helps show where Jie Shi may publish in the future.

Co-authorship network of co-authors of Jie Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Jie Shi. A scholar is included among the top collaborators of Jie Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jie Shi. Jie Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 1
3 2
4 0
5 1
6 0
7 6
8 14
9 2
10 11
11 6
12
Co-Composting of Kitchen Waste, Faeces and Sewage Sludge as Sustainable Strategy for Island Waste Management: Process Dynamics
1
13 21
14 84
15
Cloning, molecular characteristics and expression pattern of the olfactory receptor co-receptor gene of Athetis dissimilis.
2
16 57
17 9
18 25
19 132
20 32

About Jie Shi

Jie Shi is a scholar working on Hematology, Cancer Research and Genetics, having authored 48 papers that have together received 644 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (6 papers), Multiple Myeloma Research and Treatments (5 papers) and Cancer-related molecular mechanisms research (5 papers). The work is most often cited by research in Cancer Research (300 citations), Hematology (73 citations) and Molecular Biology (366 citations). Jie Shi has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Shuqun Cheng, Wei‐Xing Guo, Han‐Ming Shen, Nan Li, Shanrong Liu, Dong Xie, Jie Xue, Nan Li, Meng-Chao Wu and Shupeng Liu. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026